CD19 and multiple sclerosis: Interestingly, both neutrophil/lymphocyte and platelet/lymphocyte ratios were higher in relapsing patients compared to remitting multiple sclerosis patients and controls while CD3+ T-cells, CD4+ T-cells, CD8+ T-cells and CD19+ B-cells were lower in relapsing patients compared to remitting patients (Table 2C).